Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)/SMAD signaling pathway

References

• Khalid FA, Mehrose MY, Saleem M, et al. Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: randomised control trial. Burns. 2019;45:69–75.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Jang YJ. Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. Int J Mol Sci. 2018;19:711.
   PubMed Web of Science ®Google Scholar
• Kafka M, Collins V, Kamolz LP, et al. Evidence of invasive and noninvasive treatment modalities for hypertrophic scars: a systematic review. Wound Repair Regen. 2017;25:139–144.
   PubMed Web of Science ®Google Scholar
• Zhou H, Li N, Yuan Y, et al. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target. Basic Res Cardiol. 2018;113:37.
   PubMed Web of Science ®Google Scholar
• Rohini M, Haritha Menon A, Selvamurugan N. Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions. Int J Biol Macromol. 2018;120:310–317.
   PubMed Web of Science ®Google Scholar
• Jadhav K, Zhang Y. Activating transcription factor 3 in immune response and metabolic regulation. Liver Res. 2017;1:96–102.
   PubMedGoogle Scholar
• Li Y, Liu B, Liang C. Letter by li et al regarding article, “cardiac fibroblast-specific activating transcription factor 3 protects against heart failure by suppressing map2k3-p38 signaling”. Circulation. 2017;136:2092–2093.
   PubMed Web of Science ®Google Scholar
• Li X, Zang S, Cheng H, et al. Overexpression of activating transcription factor 3 exerts suppressive effects in hepg2 cells. Mol Med Rep. 2019;19:869–876.
   PubMed Web of Science ®Google Scholar
• Badr G, Sayed LH, Omar HEM, et al. Camel whey protein protects b and t cells from apoptosis by suppressing activating transcription factor-3 (atf-3)-mediated oxidative stress and enhancing phosphorylation of akt and ikappab-alpha in type i diabetic mice. Cell Physiol Biochem. 2017;41:41–54.
   PubMedGoogle Scholar
• Wang T, He R, Zhao J, et al. Negative pressure wound therapy inhibits inflammation and upregulates activating transcription factor-3 and downregulates nuclear factor-kappa B in diabetic patients with foot ulcerations. Diabetes Metab Res Rev. 2017;33(4).
   Web of Science ®Google Scholar
• Qian L, Zhao Y, Guo L, et al. Activating transcription factor 3 (atf3) protects against lipopolysaccharide-induced acute lung injury via inhibiting the expression of tl1a. J Cell Physiol. 2017;232:3727–3734.
   PubMed Web of Science ®Google Scholar
• Kim DE, Procopio MG, Ghosh S, et al. Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation. J Exp Med. 2017 Aug 7;214(8):2349–2368.
   PubMed Web of Science ®Google Scholar
• Wu C, Lin H, Zhang X. Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3). Int Immunopharmacol. 2019 Sep;74:105700.
   PubMed Web of Science ®Google Scholar
• Zu T, Wen J, Xu L, et al. Up-regulation of activating transcription factor 3 in human fibroblasts inhibits melanoma cell growth and migration through a paracrine pathway. Front Oncol. 2020 Apr 21;10:624.
   PubMed Web of Science ®Google Scholar
• Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016 Jun;12(6):325–338.
   PubMed Web of Science ®Google Scholar
• Cui J, Jin S, Jin C, et al. Syndecan-1 regulates extracellular matrix expression in keloid fibroblasts via TGF-β1/Smad and MAPK signaling pathways. Life Sci. 2020 Aug 1;254:117326.
   PubMed Web of Science ®Google Scholar
• Akatsu Y, Takahashi N, Yoshimatsu Y, et al. Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1. Mol Oncol. 2019 Aug;13(8):1706–1724.
   PubMed Web of Science ®Google Scholar
• Lv W, Ren Y, Hou K, et al. Epigenetic modification mechanisms involved in keloid: current status and prospect. Clin Epigenetics. 2020 Nov 26;12(1):183.
   PubMed Web of Science ®Google Scholar
• Kwon JW, Kwon HK, Shin HJ, et al. Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of nf-kappaB. Sci Rep. 2015;5:14470.
   PubMed Web of Science ®Google Scholar
• Hasim MS, Nessim C, Villeneuve PJ, et al. Activating transcription factor 3 as a novel regulator of chemotherapy response in breast cancer. Transl Oncol. 2018;11:988–998.
   PubMed Web of Science ®Google Scholar
• Vert A, Castro J, Ribó M, et al. Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of onconase. Oncotarget. 2017;8:11692–11707.
   PubMedGoogle Scholar
• Li X, Zhou X, Li Y, et al. Activating transcription factor 3 promotes malignance of lung cancer cells in vitro. Thorac Cancer. 2017;8:181–191.
   PubMed Web of Science ®Google Scholar
• Wang Z, He Y, Deng W, et al. Atf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice. Oncogene. 2018;37:18–27.
   PubMed Web of Science ®Google Scholar
• Sha H, Zhang D, Zhang Y, et al. Atf3 promotes migration and m1/m2 polarization of macrophages by activating tenascinc via wnt/betacatenin pathway. Mol Med Rep. 2017;16:3641–3647.
   PubMed Web of Science ®Google Scholar
• Li YL, Hao WJ, Chen BY, et al. Cardiac fibroblast-specific activating transcription factor 3 promotes myocardial repair after myocardial infarction. Chin Med J (Engl). 2018;131:2302–2309.
   PubMed Web of Science ®Google Scholar
• Morris E, Chrobak I, Bujor A, et al. Endoglin promotes tgf-beta/smad1 signaling in scleroderma fibroblasts. J Cell Physiol. 2011;226:3340–3348.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu H, Liang Y, et al. Dkk3 regulates cell proliferation, apoptosis and collagen synthesis in keloid fibroblasts via tgf-beta1/smad signaling pathway. Biomed Pharmacother. 2017;91:174–180.
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Fairbrother WJ, Leverson JD, et al. From basic apoptosis discoveries to advanced selective bcl-2 family inhibitors. Nat Rev Drug Discov. 2017;16:273–284.
   PubMed Web of Science ®Google Scholar
• Yadav L, Puri N, Rastogi V, et al. Matrix metalloproteinases and cancer - roles in threat and therapy. Asian Pac J Cancer Prev. 2014;15:1085–1091.
   PubMedGoogle Scholar
• Zhang J, Li Y, Bai X, et al. Recent advances in hypertrophic scar. Histol Histopathol. 2018;33:27–39.
   PubMed Web of Science ®Google Scholar
• Gordon KJ, Blobe GC. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta. 2008;1782:197–228.
   PubMed Web of Science ®Google Scholar
• Naim R, Naumann A, Barnes J, et al. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture. Aesthetic Plast Surg. 2008;32:346–352.
   PubMed Web of Science ®Google Scholar
• Mallano T, Palumbo-Zerr K, Zerr P, et al. Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis. Ann Rheum Dis. 2016 Mar;75(3):586–592.
   PubMed Web of Science ®Google Scholar
• Lei R, Li J, Liu F, et al. HIF-1α promotes the keloid development through the activation of TGF-β/Smad and TLR4/MyD88/NF-κB pathways. Cell Cycle. 2019 Dec;18(23):3239–3250.
   PubMed Web of Science ®Google Scholar